These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16120199)

  • 1. Epidemiology and clinical classification of onychomycosis.
    Effendy I; Lecha M; Feuilhade de Chauvin M; Di Chiacchio N; Baran R;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():8-12. PubMed ID: 16120199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options--development of consensus guidelines.
    Lecha M; Effendy I; Feuilhade de Chauvin M; Di Chiacchio N; Baran R;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():25-33. PubMed ID: 16120203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and management of onychomycosis in private dermatological practice in France].
    Guibal F; Baran R; Duhard E; Feuilhade de Chauvin M
    Ann Dermatol Venereol; 2008; 135(8-9):561-6. PubMed ID: 18789289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature review. Onychomycosis.
    Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():1-7. PubMed ID: 16120198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of onychomycosis with oral antifungal agents.
    Iorizzo M; Piraccini BM; Rech G; Tosti A
    Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimycotic therapy of Tinea unguium and other onychomycoses].
    Stock I
    Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1108-11. PubMed ID: 17877741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis.
    Baran R; Coquard F
    J Dermatolog Treat; 2005 Feb; 16(1):52-5. PubMed ID: 15897169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of onychomycosis].
    Gregurek-Novak T; Stipić T
    Lijec Vjesn; 1997; 119(5-6):154-7. PubMed ID: 9379823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis: classification and diagnosis.
    Gupta AK; Ryder JE; Summerbell RC
    J Drugs Dermatol; 2004; 3(1):51-6. PubMed ID: 14964746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial design--towards better practices.
    Correia O; Faergemann J; Nowicki R; Ro BI
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():40-2. PubMed ID: 16120205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001.
    Ioannidou DJ; Maraki S; Krasagakis SK; Tosca A; Tselentis Y
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):170-4. PubMed ID: 16441625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
    Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
    Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Shemer A; Nathansohn N; Kaplan B; Trau H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.